The mitochondrial intramembrane rhomboid protease Parl has been implicated in diverse functions in vitro, but its physiological role in vivo remains unclear. Here we show that Parl ablation in mouse causes a striking necrotizing encephalomyelopathy similar to Leigh syndrome, a mitochondrial disease characterized by disrupted energy production. Mice with conditional Parl deficiency in the nervous system, but not in muscle, develop a similar phenotype as germline Parl knockouts demonstrating the vital role of Parl in neurological homeostasis. Genetic modification of two major Parl substrates, Pink1 and Pgam5, do not modify this severe neurological phenotype. Parl -/brain mitochondria are affected by defects in Complex III activity and in coenzyme Q biosynthesis. Parl is necessary for the stable expression of Ttc19, required for Complex III activity, and of Coq4, essential in coenzyme Q biosynthesis. Thus, Parl plays a previously overseen constitutive role in the maintenance of the respiratory chain in the nervous system, and its deficiency causes progressive mitochondrial dysfunction and Leigh-like syndrome.
INTRODUCTION
Presenilin Associated Rhomboid Like protein 1 also called PINK1/PGAM5 Associated Rhomboid Protease 2 , both abbreviated as "PARL", represents the only known mitochondrial member of the rhomboid family. Rhomboids are an evolutionary conserved group of intramembrane cleaving proteases and pseudo proteases involved in a variety of functions 3 .
Their broad biological significance is reflected in their pathological relevance for prevalent human diseases, including cancer and neurodegenerative disease 3, 4 , including Parkinson's disease 5 .
The crucial role of PARL in cellular homeostasis is illustrated by the lethal multisystem phenotype of Parl deficient mice (Parl -/-), associated with muscle atrophy and increased apoptosis in thymus and spleen 6 . The faster cytochrome c release and cristae remodeling in vitro, the increased cell death of Parl -/-MEFs treated with apoptosis-inducing agents being rescued by overexpression of intermembrane space targeted Opa1, led to the proposal that Parl plays a crucial role in cristae remodeling and cytochrome c release during apoptosis. The authors suggested that decreased Opa1 processing by Parl was causative to these apoptotic phenotypes, although they did not exclude that Opa1 processing was also executed by other proteases. Later studies identified Oma1 and Yme1l 7 as the proteases responsible for Opa1 processing and questioned Opa1 as a Parl substrate 8 . More recently, Parl has been implicated in the processing of other substrates in cultured cells [9] [10] [11] [12] [13] [14] . Two substrates, Pink1 and Pgam5, are of particular interest as they have been implicated in the neurodegenerative disorder Parkinson's disease 15, 16 . Both accumulate in Parl -/cells [10] [11] [12] 17 , but it is unclear whether this accumulation has a pathological effect or not 2 . A recent elegant cell biology study has led to the proposal that PARL exerts pro-apoptotic effects via misprocessing of DIABLO 14 .
However, this is difficult to reconcile with the evident lethality of Parl -/mice and the proposed anti-apoptotic, protective function of Parl 6 . Overall, the available data have led to contradictory speculations with regard to the role of PARL in mitochondrial function 6, 18 , morphology 6, 18, 19 , mitophagy 5, 20, 21 and apoptosis 6, 14 and claims have not been further substantiated in vivo. More importantly, the cause of death of the Parl -/mice, and therefore the physiological role of this protease has remained unresolved. To address these questions, we decided to re-investigate Parl deficient mice. In contrast with our previous report, we find now, in addition to the previous described phenotypes in peripheral tissues, that Parl deficiency in the nervous system causes a severe dramatic necrotizing encephalomyelopathy which closely resembles pathologically Leigh syndrome, a human mitochondrial disease characterized by severe brainstem and subcortical neurodegeneration and caused by impaired energy production 22 . A similar phenotype is seen both in the full Parl -/and in Parl Nes-Cre mice with a specific deletion of Parl in the nervous system, including the atrophy of muscle, thymus and spleen seen previously in the Parl -/mice. This striking neurodegeneration is not associated with altered apoptosis but with massive necrosis raising the question of the underlying mechanism. We show that necrosis in Parl -/brains is preceded by progressive mitochondrial structural changes and biochemically by defects in Complex III function and in Coenzyme Q (CoQ) biosynthesis. Thus, Parl has an essential physiological role in the maintenance of mitochondrial structure and respiratory chain function, which is severely impaired when Parl is ablated, causing Leigh-like neurodegeneration. We discuss how these novel insights affect our previous interpretations of the Parl -/phenotype in vivo.
RESULTS

Parl deficiency in the nervous system leads to Leigh syndrome
Parl -/mice develop normally up to the age of 40 days, after which they progressively lose weight 6 . From the age of six weeks, they show rapidly progressive locomotor impairment, paresis of the lower limbs, hunchback deformity, and dyspnea. They die before the age of eight weeks from a multisystem phenotype with atrophy of skeletal muscle, thymus and spleen 6 , without a clear explanation. Immune deficiency is unlikely the underlying cause of death since mice thymus and spleen become atrophic only few days before death when mice are already severely affected. Moreover mice are bred in specific pathogen free conditions and do not develop opportunistic infections, leaving open the question of which essential vital function is compromised by Parl deficiency. These clinical signs led us to ask whether this striking phenotype was caused by involvement of the nervous system. Thus, we performed a detailed neuropathological analysis of Parl -/mice. Microscopic examination of the brain and spinal cord from Parl -/mice indeed shows a previously overlooked striking subcortical vacuolar encephalomyelopathy closely resembling Leigh syndrome ( Fig. 1A-H) . Leigh syndrome is a lethal mitochondrial disease characterized clinically by neurological regression and pathologically by vacuolar degeneration and necrosis of the brainstem, basal ganglia and spinal cord, associated with reactive gliosis and vascular proliferation 23 . Vacuolization of the neuropil is first detectable in Parl -/mice at five weeks of age, initially focally circumscribed in the brainstem and in the gray matter in the spinal cord, and then progressively extending anteriorly to hypothalamus, thalamus, deep cerebellar nuclei, and the cingulate cortex. Other areas of the brain, most notably the substantia nigra, are spared. Neuronal loss is readily detectable by the disappearance of NeuN positive cells ( Fig. 1B ). Neurodegeneration is accompanied by extensive astrogliosis and microgliosis, indicated by Gfap ( Fig. 1C ) and Iba1 ( Fig. 1D ) immunoreactivity. Luxol-fast blue, a staining used to visualize the white matter in the brain, shows comparable reaction in WT and Parl -/mice ( Fig. 1E ). Consistent with neuronal involvement, in situ hybridization shows that Parl mRNA expression is particularly abundant in neurons ( Fig. 1F ). In advanced stages, vascular proliferation becomes evident ( Fig. 1G ), and symmetrical necrohemorragic foci are frequently observed at seven weeks of age in the most severely affected areas of the brainstem and spinal cord ( Fig. 1H ). When Parl was specifically ablated in the nervous system using a Nestin-Cre driver (Parl Nes-Cre ) ( Fig. 1J ) a similar lethal phenotype is observed as in the germline Parl -/mice ( Fig. 1I ) including the Leigh type neuropathology ( Fig.1K ). Apart from a 4-weeks delay in lethality and the absence of testis atrophy ( Fig. 1O ), these mice develop the typical Parl -/multisystem phenotype 6 with severe atrophy of muscle, liver, spleen ( Fig.1L-N) , and thymus ( Fig. 1P ) despite normal Parl expression in these tissues ( Fig. 1J ) even at late symptomatic stages. Thymus and spleen become atrophic in Parl Nes-Cre as in germline Parl -/mice only in preterminal stages of the disease when the mice are already affected by severe neurological deficits. Conversely, deletion of Parl in striated muscle in Parl Ckmm-Cre knockout mice using Cre expression driven by the Creatine kinase promoter did not compromise survival beyond the age of 15 months nor led to overt locomotor deficits (n=13, Fig. 1I ). Altogether, these data suggest that Parl deficiency in the nervous system is sufficient to recapitulate the lethal multisystem phenotype of germline Parl -/mice, except the gonad atrophy.
Parl deficiency causes early neuronal mitochondrial ultrastructural abnormalities followed by neuronal necrosis
To characterize mitochondrial ultrastructure and the morphological features of cell death induced by Parl deficiency in the brain we performed electron microscopy. Examination of WT and Parl -/medulla oblongata at 3 weeks of age, which is before the occurrence of clinical signs or histopathological lesions, shows that Parl -/neurons display scattered mitochondria with abnormal cristae ( Fig S1 ). Since Parl has been linked previously to apoptosis 6, 24 , we performed biochemical experiments to investigate further the contribution of this process to the neurodegeneration.
During apoptosis, the outer mitochondrial membrane becomes permeable, and cytochrome c is released from the mitochondrial intermembrane space to the cytosol leading to proteolytic activation of executioner caspases and Parp. We analyzed mitochondrial outer membrane permeability of brain mitochondria isolated from symptomatic Parl -/mice by measuring the enhancement of complex IV-driven respiration before and after addition of exogenous cytochrome c, which is unable to reach complex IV if outer membranes are intact. Exogenous cytochrome c does not significantly enhance complex IV-driven respiration in both WT and Parl -/brain mitochondria (Fig. 3C ), indicating intactness of outer mitochondrial membranes even in advanced stages of the disease associated with severe neurodegeneration.
Consistently, cytochrome c is undetectable in purified brain cytosols from Parl -/brains ( Fig.   3D ), and the expression of full length Parp is similar in Parl -/and WT brains without evidence of proteolytic activation ( Fig. 3E ). Accordingly, we do not see TUNEL positive cells in the degenerating brain areas, notably brainstem, thalamus, hypothalamus at serial time points ranging from asymptomatic to late stage of the disease (Fig. S2A ). TUNEL positivity is restricted to few scattered cells, likely undergoing developmental apoptosis, in periventricular areas which are not affected by Parl -/neurodegeneration, to a similar extent in WT and Parl -/brains. We obtained similar results using antibodies against cleaved caspase 3 ( All together, these data indicate that the striking neurodegeneration induced by Parl deficiency is sustained by neuronal necrosis, without overtly altering the execution of apoptosis in the brain.
Parl -/-Leigh-like encephalomyelopathy is not caused by misprocessing of Pink1 and Pgam5
Next we wondered to which extent the dramatic neurodegenerative phenotype of Parl -/mice can be attributed to misprocessing of the best characterized substrates of Parl, Pink1 5,10,12 , a mitochondrial kinase, and Pgam5, a mitochondrial phosphatase 13 . Both have roles in neurological diseases 15, 16 and in mitophagy 16, 25 . Pgam5 have also been linked to regulation of multiple cell death pathways including necroptosis 26 . However, the contribution of Pink1 and Pgam5 misprocessing to the Parl -/phenotype is not known 2 . Pink1 is barely detectable in WT mitochondria, while a remarkable accumulation of Pink1 substrate is seen in Parl -/brain mitochondria ( Fig. 4A) . Similarly, the unprocessed full-length form of Pgam5 strongly accumulates in Parl -/mitochondria while the processed Pgam5 forms runs slightly faster than in WT mitochondria, indicating an alternative Parl-independent cleavage. To test whether accumulation of these unprocessed forms of Pink1 and Pgam5 in Parl -/mitochondria drives Parl -/neurodegeneration, we generated a series of double Parl -/-/Pink1 -/-, Parl -/-/Pgam5 -/-, and triple Parl -/-/Pink1 -/-/Pgam5 -/combined knock out mice ( Fig.4A) . Surprisingly, the Parl -/phenotype is unmodified by simultaneous deletion of Pink1, or Pgam5, either alone or together, and all these mouse strains invariably died at a similar age as the single Parl -/- (Fig.4B ) affected by similar Leigh like syndrome ( Fig.4C ). To test whether deficient proteolytic products of Pink1 and Pgam5 generated by Parl were essential, we also generated Leigh syndrome is a genetically heterogeneous disease caused by different genetic defects that ultimately impair mitochondrial energy production 22 Therefore, we performed a thorough biochemical characterization of Parl -/brain mitochondria to address how mitochondrial function is compromised by absent Parl expression. Since Parl has been previously linked to differences in mitochondrial biogenesis 18 , we asked whether mitochondrial mass is affected in Parl -/brains. Expression of respiratory chain subunits and of the outer membrane resident proteins Tomm20 and Vdac1 is similar in WT and Parl -/brains at any age ( Fig. 5A ), indicating unaltered mitochondrial mass. Mitochondrial DNA abundance was also not significantly different between WT and Parl -/brains ( Fig. 5B ). Next, we measured oxygen consumption rates in neuronal mitochondria derived from permeabilized synaptosomes by high-resolution respirometry supplying consecutively substrates and specific inhibitors for Complexes I, II, and IV according to the protocol illustrated in Fig. 5C . Importantly, at three weeks of age, which is three weeks before the first clinical signs of Parl -/mice, mitochondrial respiration is comparable between WT and Parl -/brain mitochondria ( Fig. S3A ). However, at six weeks of age, both ADP stimulated respiration (OXPHOS), providing a measurement of the maximal capacity to generate ATP, and uncoupled respiration, providing an estimate of the maximal electron transfer capacity (ET), are severely diminished in Parl -/neuronal mitochondria ( Fig. 5D ). This was similar whether they were supplied with only Complex I substrates (CI OXPHOS), or by combined supply of Complex I and II (CI+II OXPHOS and ET). Cytochrome c oxidase, catalyzing the final step in the electron transfer chain, is only slightly, although still significantly compromised ( Fig. 5D ). Thus, the mitochondrial respiration defect is limited by impaired electron transfer capacity particularly in respiratory chain segments proximal to cytochrome c oxidase. Next, to localize precisely the respiratory chain defect, we measured the maximal enzymatic activities of each of the respiratory chain complexes (CI-CIV) and of ATP synthase in brain mitochondria, as well as the coupled enzymatic activity of CII+III. This latter enzymatic assay explores the capacity of mitochondria supplied with succinate to transfer electrons to cytochrome c, therefore exploring the overall integrity of the respiratory chain in the segment Complex II-coenzyme Q-Complex III. We detected a severe enzymatic defect of Complex III and of Complex II+III ( Fig. 5E ), while the enzymatic activities of Complex II and IV are slightly, although significantly, decreased. Next, we wondered whether the deficient Complex III activity was due to abnormal Complex III assembly. Blue native gel electrophoresis of brain mitochondria showed an effective assembly and maturation of the four respiratory chain complexes I-IV and of ATP synthase, as well as preserved formation of the super complex ( Fig. 5F ). The terminal component of complex III, the iron sulfur cluster protein Uqcrfs1, is normally incorporated 27 but complex III showed consistently a slightly lower electrophoretic mobility in Parl -/mitochondria ( Fig. 5F ). An identical CIII2 migration abnormality has been recently reported in mitochondria deficient of Ttc19 28 , a protein required for the maintenance of Complex III enzymatic activity through the regulation of Uqcrfs1 turnover. Interestingly, gene mutations in TTC19 cause human Leigh syndrome 29 . Next to investigate unambiguously the possibility of a CoQ deficiency in presence of a simultaneous enzymatic defect of isolated Complex III and CII+III ( Fig.5E ), we directly measured CoQ levels (CoQ9+10) in whole brain extracts and the ratio between reduced and oxidized CoQ, a sensitive marker of the electron transfer efficiency of the respiratory chain 30 . CoQ deficiency is one of the established causes of Leigh syndrome 22 . Remarkably, total CoQ levels are severely decreased in Parl -/brains at seven weeks of age ( Fig. 5G) . Moreover, the ratios between reduced and oxidized forms of both forms of CoQ are dramatically increased (Fig. 5H ) indicating a marked impairment in CoQH2 oxidation, consistent with the impaired Complex III activity identified above. These changes are, in contrast to the respiration defect, already severe at three weeks of age ( Fig.S3B ) when the mice are asymptomatic, indicating that CoQ deficiency is an early effect of Parl deficiency. In conclusion, Parl is required to prevent severe mitochondrial dysfunction in brain mitochondria characterized by Complex III and CoQ biosynthesis defects.
Mitochondrial proteome changes induced by Parl deficieny in the brain
We wondered what mitochondrial protein changes underlie theParl -/-Leigh-like phenotype and the observed Complex III and CoQ biosynthesis defects. We performed a mass spectrometry-based proteome analysis of brain mitochondria purified from three WT and three Parl -/mice, leading to the quantification of 781 out of 1085 proteins annotated in the mouse mitochondrial proteome in Swissprot. The volcano plot shows that despite the dramatic phenotype, surprisingly few mitochondrial proteins are differentially expressed in Parl -/compared to WT brains ( Fig. 6A ), indicating selective effects of Parl on the mitochondrial proteome. Among these, we find a striking downregulation of the Complex III regulating protein Ttc19 28,31 and of several proteins required for CoQ biosynthesis (Coq3, Coq4, Coq5).
We also notice the significant decrease of the sulfide-CoQ oxidoreductase Sqrdl, which has been recently reported to decrease in human diseases caused by primary CoQ defects 32 .
Interestingly, other known CoQ oxidoreductases such as electron transfer flavoproteinubiquinone oxidoreductase (Etfdh), glycerol 3-phosphate dehydrogenase (Gpd2), dihydroorotate dehydrogenase (Dhod), proline-dehydrogenase (Prodh), and choline dehydrogenase (Chdh) are not affected. Ghitm, a multipass inner membrane protein not previously linked to Parl, also decreases. Conversely, similar Pgam5 also Diablo 14 is increased in Parl deficient brain mitochondria ( Fig. 6B ). Next, we validated these findings by western blot in brain mitochondria from WT, Parl -/-, and Parl Nes-Cre (Fig. 6B ). Since our proteomic approach identifies substrates by expression changes, we decided to include in the validation also the previously reported Parl substrates Htra2 9 , Opa1 6 , Stard7, and Clpb 14 , which were not significantly different in our mass spectrometry analysis ( Fig. 6A ). Western blots confirm the virtual disappearance of Ttc19, a marked reduction of the CoQ proteins (Coq3,Coq4,Coq5), Sqrdl, and Ghitm, and altered cleavage of Ttc19, Pgam5, Diablo, Stard7, and Clpb. The expression and processing of Htra2 and Opa1 are not impaired ( Fig. 6B ). To correlate these protein changes with the clinical phenotype, we checked their expression in brain tissue over time, at the age of 1, 3, and 5 weeks, when Parl -/mice are still asymptomatic, and at 7 weeks, when the mice are severely affected by neurological deficits To explore to what extent the catalytic function of Parl is involved in these protein changes, we checked the expression of these proteins in stable Parl -/-MEFs expressing Parl WT or catalytic inactive Parl S275A (Fig. S5 ). We observed no altered mobility of Coq4, Coq5, Sqrdl in Parl -/cultured MEFs, suggesting that they likely are not direct Parl substrates. In contrast, the processing of Ttc19, Pink1, Pgam5, Stard7, Diablo, and Clpb is clearly modified by expression of catalytically active Parl, but not by mutant Parl S275A , confirming that Parl proteolytic activity is required for the maturation of these proteins and that they are all likely genuine Parl substrates 14 . In contrast, we could again not confirm differences in Htra2 and Opa1 processing in Parl -/cultured MEFs suggesting that both these proteins are not Parl substrates in contrast to what previously proposed 6,9 . To dissect the relationship between the Ttc19 deficiency and the observed CoQ defects we generated Ttc19 -/mice ( Fig. 6D-E ). These mice (20 out of 20) have not shown any reduced survival although they seem to show a slight reduction in locomotor activity at one year of age. Coq4 expression is normal in Ttc19 -/- (Fig. 6E ) as well as CoQ concentration (Fig. 6F ).
Conversely, CoQ red/ox ratio is dramatically increased in Ttc19 -/brains ( Fig. 6G) , as in the Parl -/- (Fig. 5G ). Thus, deficiency of mature Ttc19 in Parl -/brains explains the abnormally increased CoQ red/ox ratio, consistent with the defective Complex III activity, but not the CoQ biosynthesis deficit. Altogether, the data indicate that Parl is required for the maintenance of Complex III activity by stabilization of Ttc19, and for efficient CoQ biosynthesis by stabilizing Coq4 expression ( Fig. 7A-B ).
DISCUSSION
This work reveals an essential role of Parl for the homeostasis of the nervous system. Deficiency of Parl in the nervous tissue whether isolated or in the context of systemic Parl knockout, leads to a striking neurodegeneration rather similar, from a neuropathological point of view, to the phenotype of the Complex I deficient Ndufs4 -/mouse 33, 34 , the only currently available mouse model for Leigh syndrome. Although much caution is needed when extrapolating from mouse models to human diseases, this study prompts to investigate whether or not PARL gene mutations are present in human patients with unexplained Leigh disease or Leigh-like syndromes. Deletion of Parl in the nervous system alone in Parl Nes-Cre largely mimics the phenotype of germline Parl -/-, as Ndufs4 Nes-Cre recapitulates that of germline Ndufs4 -/-, indicating that in both models the nervous system involvement drives the disease. The molecular basis for this remarkable tissue specificity remains unclear for mouse and human Leigh syndrome, as well as for most of the major neurological diseases.
Nevertheless, this observation demonstrates that the Leigh syndrome is actually the elusive cause of the multisystem lethal phenotype of the previously generated Parl -/mice 6 .
Interestingly, severe neurological alterations have also been observed in flies carrying mutations in the Parl fly orthologue rhomboid-7 35 .
Previous work focused on the potential role of Parl in apoptosis but has not noticed this severe neuropathological phenotype 6 . We are currently investigating why this phenotype was overlooked before. From the current data it is in any event clear that the specific deletion of Parl in the nervous system alone in the Parl Nes-Cre mice is sufficient to cause a similar lethal multisystem phenotype as germline Parl -/mice, including severe atrophy of skeletal muscle thymus and spleen atrophy 6 , although with a delay of about one month. Theoretically, we cannot fully exclude nonspecific Cre recombinase activity driven by Nestin in scattered cells in tissues outside the nervous system (https://www.jax.org/strain/003771). However, as shown in Fig 1J Parl protein expression in these tissues was consistently comparable to WT animals suggesting that nonspecific deletion of Parl in the peripheral tissues of Parl Nes-Cre mice is minimal. Moreover, the lack of overt muscle atrophy and lethality in mice with specific deletion of Parl in muscle, as opposed to the nervous system, indicates that the severe muscle atrophy is mainly caused by the neurodegeneration. This might be due to denervation, and this hypothesis is supported by the widespread degeneration of neurons in the spinal cord grey matter, including in the anterior horns where cell bodies of the lower motor neurons are localized. Brain specific deletion of the mitochondrial protease Htra2 affects thymus and spleen in a similar way as brain specific Parldeficiency 36 . Such immunological phenotypes can be caused by a variety of general stress conditions that trigger increased secretion of corticosteroids and other stress response hormones 37 . Hind limb unloading for instance induces the distinctive depletion of double positive CD4+CD8+ T lymphocytes that is also observed in Parl -/thymus and drop of B lymphocytes in Parl -/spleen 6 , but other general stress conditions such as malnutrition 38 , amyotrophic lateral sclerosis 39 and cerebrovascular accidents 40 can have similar effects on thymus and spleen. This is consistent with the observation that Parl -/and Parl Nes-Cre mice develop these immunological manifestations only in late stages of the disease when they are already affected by severe neurological deterioration.
Surprisingly, despite the striking neuropathological phenotype, the absence of Parl affects only a very circumscribed proportion of the brain mitochondrial proteome, which overlaps with recent proteomic data obtained in HEK293 cells by Chafradic and quantitative affinity purification 14 . At odd with previous observations 6, 9 and consistent with following reports 14, 41 , the data presented here do not support Opa1 and Htra2 as substrates of Parl.
Conversely, we find that several of the few proteins that are differentially regulated by Parl are known to play important roles in neurological diseases. We tested explicitly whether the accumulation of Pink1 and Pgam5, two substrates of Parl known to be involved in Parkinson's disease 15, 16 and mitophagy 16, 25 , could be responsible for the pathological phenotype of the Parl-/-mice. Pgam5 has also been reported to modulate necroptosis and other cell death modalities at least in vitro 26 . Rare PARL mutations have been reported in few patients with Parkinsons's disease 5 . We tested combined knockouts of these two substrates with Parl -/to evaluate whether their accumulation caused the lethality. We also tested separately their combined deletion in the presence of Parl to check whether the loss of function of these two substrates would play a role in the Parl -/phenotype. Both experiments did not modulate or simulate the Parl -/phenotype. Thus Pink1 and Pgam5 15, 16, 25 are not responsible for the Leigh-like pathology in the Parl -/mice suggesting that other biochemical mechanisms are involved. Moreover, the normal survival and lack of striking clinical phenotypes in Pink1 -/-/Pgam5 -/suggests that these proteins are not essential for mitochondrial turnover in vivo.
Here we show that Parl is essential for the maintenance of the respiratory chain function independently from effects on mitochondrial mass 18 Impaired proteolytic maturation of Ttc19 by Parl likely leads to its degradation by alternative mitochondrial proteases. Ttc19 is involved in the turnover of the iron-sulfur protein Uqcrfs1 28 , a structural subunit of Complex III essential for the catalytic activity that ensures CoQ oxidation. When this activity is normal, CoQ red/ox ratio is low, while it is high when Complex III is dysfunctional, as in the case of the Parl -/mice. In addition, and independently from Ttc19, Parl ensures CoQ biosynthesis by stabilization of Coq4, a protein required for the biosynthesis of this electron acceptor 42 . Intriguingly, the profound CoQ deficiency that we found in Parl -/brains is followed by a secondary reduction in the expression of Sqrdl, as also recently observed in models of primary CoQ defects 32, 43 . This hydrophobic molecule serves essential functions in mitochondrial membranes both as an electron carrier from several metabolic pathways to Complex III and as membrane antioxidant 44, 45 The Ttc19 -/mice data indicate that the CoQ deficiency is independent from the complex III defect. Interestingly, human mutations in TTC19 29 , and in genes that induce CoQ deficiency 22 are independent causes of Leigh syndrome 48 . In addition, COQ4 haploinsufficiency is sufficient to cause neurodegeneration in human 48 . Although deletion of Ttc19 only causes mild neurodegeneration in mouse 28 , we propose that the combination of the defects in Complex III activity and in CoQ biosynthesis could play an important role in the severe mitochondrial dysfunction that we observe in Parl -/neuronal mitochondria.
Since the original description of Parl -/mice 6 , many studies have focused on the possible link between Parl and apoptosis in vitro. The results of these investigations have been controversial and both pro-and anti-apoptotic mechanisms have been proposed 6, 9, 24 . Here we show that Parl deficiency leads to neuronal necrosis in vivo, and that the effects on apoptosis in vivo, such as those observed in thymus and spleen, appear largely indirect. We speculate that the necrotic phenotype we observed in the nervous system may represent a tissue specific consequence of the severe structural and functional damage that progressively accumulate in neuronal mitochondria, rather than the result of a direct gatekeeping activity of Parl in regulated necrosis machineries. Although we were not able to define in further detail whether necrosis is regulated or not in Parl -/brains, the neuropathological phenotype is consistent with the definition of Leigh syndrome as a necrotizing encephalomyelopathy. Future studies may investigate whether any subroutine of regulated necrosis is implicated or not in Parl -/neurodegeneration. Our work indicates that Parl has a constitutive physiological role in keeping the respiratory chain function and structural integrity in check, with important consequences for the nervous system.
MATERIALS AND METHODS
Mice
Mice conditionally targeted and full knock out for Parltm1Bdes (Parl lox/lox ), Parltm1.1Bdes(Parl -/-) were previously generated 6 . Nervous system specific Parl -/mice, called Parl Nes-Cre , were generated by crosses with Tg(Nes-Cre)1Kln 49 
Pathological analysis
Parl -/mice and matched WT controls at 2-8 weeks of age were used. Animals were anesthetized with a mixture of xylazine (25 mg/ml), ketamine (20mg/ml) and atropine (20ng/ml), followed by intracardial perfusion of ice-cold phosphate buffered saline (PBS, 10 mL) and ice-cold paraformaldehyde (4% PFA). Head and spine were fixed for additional 48 hrs in 4% PFA at 4 °C. After fixation, brain was removed from the skull and serially sliced using the coronal brain matrix system (Zivic Instruments BSMYS001-1). Five slices were obtained from each brain using the following anatomical landmarks as references:
paraflocculi, mammillary body, optic chiasm, olfactory tubercles. Spine was decalcified in a supersaturated solution of tetrasodium EDTA and cross-sectioned at the level of cervical, thoracic and lumbar segments. Samples were embedded in paraffin blocks. Five μm thick sections were stained with hematoxylin and eosin (H&E). Some sections were stained with Luxol Fast Blue, TUNEL or with antibodies against Gfap, Iba-1, NeuN, or Cleaved Caspase-
Microscopic lesions were classified according to the International Harmonization of
Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice INHAND criteria 52
In situ hybridization
In situ hybridization (ISH) was performed as described previously 53 . A cDNA-containing construct of Parl was generated in the pGemT-easy vector system (Promega). Digoxigeninlabeled antisense and sense RNA probes were generated by in vitro transcription of linearized plasmid using T7 and SP6 RNA polymerase (Roche), respectively. Brains were collected, fixed with 4% paraformaldehyde overnight, washed with PBS, dehydrated and embedded in paraffin. ISH was performed on 6 µm brain sections using an automated platform (Ventana Discovery, Ventana Medical Systems). Images were obtained by light microscopy and captured with a CH250 CCD camera (Photometrics, Tucson, AZ).
Electron microscopy
Mice of the indicated genotype were transcardially perfused with 2.5% glutaraldehyde, 2% Images were taken at magnifications ranging from 1500X to 15000X.
Subcellular fractionation methods
Brain mitochondria purification was adapted from the Sims method 54 . Brains were rapidly excised, finely chopped with a scissor and homogenized with a Teflon-glass potter in 20 volumes of 20 mM Hepes, 225 mM sucrose, 75 mM mannitol, 1 mM EGTA pH 7.4, on ice.
The homogenate was centrifuged at 900 g for 10 minutes at 4C to remove nuclei and unbroken debris. The supernatant (tissue homogenate) was then centrifuged at 15'000 g for 10 minutes at 4°C. The pellet is the crude brain mitochondrial fraction. The supernatant was spun at 120'000 g for 60 minutes at 4°C to remove particles and the collected supernatant was purified cytosol. The crude brain mitochondrial fraction was re-suspended in 15% Percoll and spun over a discontinuous 24/40% Percoll gradient for 6 minutes at 31,000 g at 4°C. The upper phase containing mainly myelin was discarded. A thick band in the interphase between 15/24% Percoll contains the synaptosomes. Free brain mitochondria were collected at the interphase between 24/40% Percoll. Free brain mitochondria and synaptosomes were washed in isolation buffer to remove residual Percoll. Cultured cells were pelleted by centrifugation and re-suspended in 10 mM Hepes, sucrose 0,28 M, 1 mM EDTA buffer, pH 7.4 on ice, gently homogenized with a syringe through a 24G needle, followed by a 26G needle, and centrifuged at 800 g for 10 minutes at 4°C. The supernatant was centrifuged at 9000 g for 10 minutes at 4°C. The pellet is the enriched mitochondrial fraction.
To obtain brain nuclear enriched fraction, brain tissue was homogenized in 10 mM Hepes, 1.5 mM MgCl2, 10 mM KCl, 1mM dithiotreitol, pH 7.9 with a Teflon-glass tissue homogenizer on ice. Nuclei and unbroken debris were pelleted by centrifugation at 1000 g for 10 minutes at 4°C. Aliquots of 20 mM Hepes, 0.42 M NaCl, 25% (v/v) glycerol, 1.5 mM MgCl2, 10 mM KCl, 0.2 mM EDTA, 1mM dithiotreitol, pH 7.9 were added to the pellet and mixed by gentle mixing, followed by manual homogenization to facilitate nuclear extraction. The solution was gently mixed for 30 minutes at 4°C, and then centrifuged at 20'000 g for 10 minutes. The supernatant represents the nuclear enriched fraction.
Total tissue and cell culture lysates were obtained by lysis in radioimmunoprecipitation assay (RIPA) buffer on ice and 5 passages with a 26G syringe, followed by centrifugation at 20,000 g for 10 minutes at 4°C to remove unbroken debris.
Immunoblot analysis
Samples were separated in reducing and denaturing conditions in NuPage gels (Invitrogen).
Proteins were transferred to PVDF 0.45µm membranes, blocked with milk 5%Tris-buffered saline, Tween 20 0,1% (TTBS), and incubated with the indicated primary antibodies, washed in TTTBS incubated for 1 hour at room temperature with horseradish peroxidase conjugated secondary antibodies (Biorad) in 5% milk-TTBS, and washed in TTBS. Chemiluminescence with ECL (Amersham) and an Image Quant LAS 4000 mini was used to visualize the proteins.
Blue native gel electrophoresis
Blue native gel electrophoresis of digitonin-solubilized mitochondria was performed as described 55 . 100 µg isolated mitochondria were solubilized with 600 µg digitonin in Invitrogen Native Page sample buffer on ice for 20 minutes, then centrifuged at 20,000 g for 20 minutes at 10 C at 4 C. 0,75% Coomassie G-250 was added to supernatants, which were loaded on a 3-12% gradient Invitrogen Native Page gel according to the instructions. After electrophoresis, mitochondrial complexes and super complexes were either visualized by protein staining with Expedeon Instant Blue or immunoblotted on a PVDF membrane and probed with the indicated antibodies.
High-resolution respirometry
Brain mitochondria respiration was measured in Miro6 Buffer 56 (20 mM Hepes, 110 mM sucrose, 10 mM KH2PO4, 20 mM taurine, 60 mM lactobionic acid, 3 mM MgCl2, 0.5 EGTA, pH 7.1, 1 mg/ml fatty acid free BSA, catalase 280 U/ml) at 37 °C. When needed 200 µM H202 was added to reoxygenate the chambers by catalase mediated O2 generation. 20 µg of purified free brain mitochondria or 50 µg synaptosomes were loaded into the Oroboros 2K oxygraph.
A typical experiment is illustrated in Fig. 5C . Oxygen consumption rates were measured before and after addition of the following sequence of substrates and specific inhibitors: 1) 2.5 mM pyruvate, 10 mM glutamate, and 1 mM malate to measure Complex I-driven leak respiration (CI leak), 2) 2.5 mM ADP to determine complex I-driven phosphorylating respiration (CI OXPHOS). When using synaptosomes, digitonin was titrated up to 15 µg/ml to achieve synaptosomal permeabilization resulting in maximal substrate accessibility to neuronal mitochondria and maximal CI OXPHOS 3) 5 mM succinate to determine the phosphorylating respiration driven by simultaneous activation of complex I and II (CI+II OXPHOS). 4) Titrating concentrations of the mitochondrial uncoupler CCCP to reach the maximal uncoupled respiration (CI+II electron transfer capacity, ET). 5) 200 nM rotenone to fully inhibit complex I-driven respiration and measure complex II-driven uncoupled respiration (CII electron transfer capacity, CII ET). 6) 0.5 µM Antimycin A to block mitochondrial respiration at the level of complex III. Residual oxygen consumption was always negligible. 7) 2 mM ascorbate, 0.5 mM TMPD to measure cytochrome c oxidase (CIV)-driven respiration. 8) 125 µg/ml cytochrome c to evaluate mitochondrial outer membrane integrity 9) 500 µM potassium cyanide to specifically block cytochrome c oxidase activity and measure residual background oxygen consumption caused by chemical interaction between ascorbate and TMPD. Cytochrome c oxidase-driven respiration was calculated as the cyanide sensitive oxygen consumption.
Mitochondrial respiratory chain enzyme analysis and CoQ determinations
Respiratory chain measurements were performed according to previously described protocols 57, 58 . Freeze-thawed crude brain mitochondrial fractions were resuspended in 20 mM Tris, EDTA 2 mM, pH 7.4. An aliquot was kept for CII+III activity measurements which rely on the local concentration of CoQ10 pools, while the rest was sonicated on ice with a Branson microtip sonicator at power 20%, 5 seconds ON and 20 seconds OFF for three consecutive times. Briefly, Complex I (NADH:ubiquinone oxidoreductase) activity was measured by recording the rotenone-sensitive decrease in absorbance due to oxidation of NADH at 340 nm (ε = 6.2 mM -1 x cm -1 ) in potassium phosphate 50 mM, pH 7.5, BSA 3 mg/ml, KCN 300 µM.
The reaction was started by addition of ubiquinone. Complex II (succinate dehydrogenase) activity was measured by following the reduction of 80 µM 2,6-dichlorophenolindophenol at 600 nm (ε = 19.1 mM -1 x cm -1 ) in potassium phosphate 25 mM, pH 7.5, succinate 20 mM, BSA 1 mg/ml, KCN 300 µM. The reaction was started with 50µM decylubiquinone.
Complex III (ubiquinol cytochrome c oxidoreductase) activity was measured by following the CoQ content and the ratio of the reduced vs. oxidized forms were measured as described 59 .
Antibodies
A Parl carboxy-terminal antibody was generated in house as previously reported 6 
Proteomic sample preparation
Mitochondria isolated from brain of WT and Parl -/mice were lysed in urea buffer (8 M µl of the following fractionation buffers: 100 mM ammonium acetate, 0.5% FA (fraction 1); 175 mM ammonium acetate, 0.5% formic acid (FA) (fraction 2); 375 mM ammonium acetate, 0.5% FA (fraction 3). Remaining peptides were eluted in 2 x 20 µl of elution buffer (5% NH4OH in water/ACN (20:80, v/v)) (fraction 4). To prevent deamidation in this fraction, 2 µl 10% FA was added. Fractionated peptides were dried in a vacuum concentrator. Proteins were only identified by site, reverse database hits, and potential contaminants were removed and replicate samples were grouped. Proteins with less than three valid values in at least one group were removed and missing values were imputed from a normal distribution around the detection limit. In this way, a total of 2,154 proteins were quantified. Then, a t-test was performed (FDR=0.05 and S0=0.5) to reveal proteins that are significantly different between WT and Parl -/samples and to generate the volcano plot depicted in Fig.6A .
LC-MS/MS and data analysis
Plasmids
All mouse Parl mutants were constructed using the QuickChange II XL mutagenesis kit Briefly, E14,5 mouse whole brains were trypsinized, dissociated with fire-polished Pasteur pipets, and plated onto poly-L-lysine (Sigma)-coated culture dishes. Cells were incubated for the first 4 hr in minimum essential medium (MEM) with 10% horse serum and then maintained in serum-free neurobasal medium with B7 supplement (Gibco). All cells were incubated at 37°C with 5% CO2. When specified, after one week in culture, neurons were treated with 10µM etoposide for 24h before collection.
Statistical analysis
All numerical data are expressed as mean ± SD. Two sided student's t test was used to compare differences between two groups. Statistical significance for survival curves was calculated by log-rank (Mantel-Cox). Differences were considered statistical significant for p Parl/Pgam5/Pink1 -/triple knockout mice. Brain mitochondria were isolated from mice of the indicated genotype and analysed by SDS page followed by immunoblotting with Parl, Pink1, and Pgam5 antibodies. The white arrow indicates the mature form of Pgam5, the black arrow indicates the unprocessed form, the grey arrow indicates alternatively processed form in Parl -/mitochondria. Hsp60 is the loading control. (B) Kaplan-Meier survival curves of Parl -/-(n=10), Pink1/Pgam5 -/-(n=10) -, Parl/Pink1 -/-(n=17), Parl/Pgam5 -/-(n=16), Parl/Pink1/Pgam5 -/-(n=13). (C) Representative H&E staining of midbrain coronal sections of seven week-old mice of the indicated genotypes (n>3 for each genotype). Scale bar: 500 µm. Restricted changes in the brain mitochondrial proteome induced by Parl deficiency explain the Complex III and CoQ defects (A) Volcano plot showing differentially regulated proteins in Parl -/brain mitochondria. purified from 5 week-old WT and Parl -/brains (n=3) analyzed by mass spectrometry. Significantly differentially regulated proteins are distributed outside the volcano cutoff of fold changes >2 and p value <0.05. Significantly differentially expressed mitochondrial proteins are plotted in red. Previously reported Parl substrates that did not reach statistical significance are plotted in black. The non-mitochondrial proteins Trabd, Bcap31, Bcan, Eif1a, and Setdb, appeared similarly expressed as from the validation experiment in Fig.5B and therefore were not included in the graph. (B) Validation of the mass spectrometry results and of previously reported Parl substrates Stard7, Clpb, Htra2, Opa1. Twenty µg of mitochondria isolated from brain of WT, Parl -/-, and Parl Nes-Cre , were analyzed by SDS page followed by immunoblotting. The white arrows indicate the mature (processed) form of the protein, the black arrows indicate unprocessed forms, the grey arrows indicate alternatively processed forms in Parl -/mitochondria. The asterisk indicates bands of uncertain significance. (C) Time course of the protein expression of Ttc19, CoQ biosynthesis proteins and Sqrdl in WT and Parl -/brains. 20 µg of total brain lysates from WT, Parl -/sacrificed at 1, 3, 5, and 7 weeks of age (n=3), were analyzed by SDS page followed by immunoblotting. The graph bars indicate the quantifications of the western blot results, normalized with the loading control Hsp60 and expressed as % relative to the WT. The original western blots are shown in SI Appendix, Fig.S5 . (D) Generation of Ttc19 -/mice by Crisper/Cas9 technology. Ttc19 -/mice have a 5 base pairs deletion in the first exon. (E) Immunoblot analysis of brain and muscle mitochondria (20 µg) with anti Ttc19 and anti Coq4 antibodies. Hsp60 is the loading control. (F) Concentration of total CoQ Q (Q9+Q10) were measured by HPLC in brain tissue from7 weeks old WT and Ttc19 -/mice (n=5 for each genotype). (G) Ratio between reduced and oxidized CoQ from 7 weeks old WT and Ttc19 -/mice from the experiment in F. The bar graphs indicate the average ± SD. Statistical significance has been calculated by two sided student t test: ****=p<0,0001. 
